DK1890698T3 - Fremgangsmåde til fremstilling af et nikotinafgivelses-produkt - Google Patents
Fremgangsmåde til fremstilling af et nikotinafgivelses-produktInfo
- Publication number
- DK1890698T3 DK1890698T3 DK06742444.0T DK06742444T DK1890698T3 DK 1890698 T3 DK1890698 T3 DK 1890698T3 DK 06742444 T DK06742444 T DK 06742444T DK 1890698 T3 DK1890698 T3 DK 1890698T3
- Authority
- DK
- Denmark
- Prior art keywords
- nicotine
- preparation
- release product
- mixture
- nicotine release
- Prior art date
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title abstract 6
- 229960002715 nicotine Drugs 0.000 title abstract 6
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract 2
- 239000003729 cation exchange resin Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229920005862 polyol Polymers 0.000 abstract 1
- 150000003077 polyols Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
- A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200500796 | 2005-06-01 | ||
| PCT/DK2006/000307 WO2006128468A1 (en) | 2005-06-01 | 2006-06-01 | A method of manufacturing a nicotine delivery product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1890698T3 true DK1890698T3 (da) | 2010-03-29 |
Family
ID=36778046
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06742444.0T DK1890698T3 (da) | 2005-06-01 | 2006-06-01 | Fremgangsmåde til fremstilling af et nikotinafgivelses-produkt |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8986668B2 (da) |
| EP (1) | EP1890698B1 (da) |
| AT (1) | ATE448786T1 (da) |
| DE (1) | DE602006010542D1 (da) |
| DK (1) | DK1890698T3 (da) |
| WO (1) | WO2006128468A1 (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8642016B2 (en) | 2006-07-21 | 2014-02-04 | Jsrnti, Llc | Medicinal delivery system, and related methods |
| US20110268809A1 (en) | 2010-04-28 | 2011-11-03 | Paul Andrew Brinkley | Nicotine-Containing Pharmaceutical Compositions |
| US20110274628A1 (en) | 2010-05-07 | 2011-11-10 | Borschke August J | Nicotine-containing pharmaceutical compositions |
| WO2011150959A1 (en) * | 2010-05-31 | 2011-12-08 | Fertin Pharma A/S | Formulation comprising nicotine and a cation exchange resin |
| WO2011150960A1 (en) * | 2010-05-31 | 2011-12-08 | Fertin Pharma A/S | Formulation comprising nicotine and a cation exchange resin |
| US20130078307A1 (en) | 2011-09-22 | 2013-03-28 | Niconovum Usa, Inc. | Nicotine-containing pharmaceutical composition |
| US9084439B2 (en) | 2011-09-22 | 2015-07-21 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
| US9474303B2 (en) | 2011-09-22 | 2016-10-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
| US9629392B2 (en) | 2011-09-22 | 2017-04-25 | R.J. Reynolds Tobacco Company | Translucent smokeless tobacco product |
| US9907748B2 (en) | 2011-10-21 | 2018-03-06 | Niconovum Usa, Inc. | Excipients for nicotine-containing therapeutic compositions |
| US9763928B2 (en) | 2012-02-10 | 2017-09-19 | Niconovum Usa, Inc. | Multi-layer nicotine-containing pharmaceutical composition |
| US20140255452A1 (en) | 2013-03-11 | 2014-09-11 | Niconovum Usa, Inc. | Method and apparatus for differentiating oral pouch products |
| US10130120B2 (en) | 2013-03-15 | 2018-11-20 | Altria Client Services Llc | Use of pectin or other anionic polymers in the stabilization and controlled release of nicotine in oral sensorial tobacco products or nicotine containing non-tobacco oral sensorial products |
| US20170165252A1 (en) | 2015-12-10 | 2017-06-15 | Niconovum Usa Inc. | Protein-enriched therapeutic composition |
| EP3445344B1 (en) | 2016-04-21 | 2020-08-19 | Fertin Pharma A/S | Nicotine delivery product, related uses and oral dosage forms, and methods of production |
| WO2018233795A1 (en) * | 2017-06-23 | 2018-12-27 | Fertin Pharma A/S | Nicotine pouch |
| EP3807260B1 (en) | 2018-06-15 | 2024-09-18 | R. J. Reynolds Tobacco Company | Purification of nicotine |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3901248A (en) | 1970-07-22 | 1975-08-26 | Leo Ab | Chewable smoking substitute composition |
| US3845217A (en) * | 1972-11-16 | 1974-10-29 | Helsingborg L Ab | Buffered smoking substitute compositions |
| US6607752B2 (en) | 2000-07-27 | 2003-08-19 | Rohm And Haas Company | Method for the anhydrous loading of nicotine onto ion exchange resins |
| WO2003061709A1 (en) * | 2002-01-18 | 2003-07-31 | Advanced Phytonics Limited | A method for preparing resinates |
| US6586449B1 (en) * | 2002-05-28 | 2003-07-01 | Cambrex Charles City, Inc. | Nicotine-containing, controlled release composition and method |
| ATE439839T1 (de) * | 2003-12-02 | 2009-09-15 | Fertin Pharma As | Nikotin-abgabeprodukt und herstellungsverfahren |
-
2006
- 2006-06-01 WO PCT/DK2006/000307 patent/WO2006128468A1/en not_active Ceased
- 2006-06-01 US US11/921,199 patent/US8986668B2/en active Active
- 2006-06-01 DE DE602006010542T patent/DE602006010542D1/de active Active
- 2006-06-01 AT AT06742444T patent/ATE448786T1/de not_active IP Right Cessation
- 2006-06-01 DK DK06742444.0T patent/DK1890698T3/da active
- 2006-06-01 EP EP06742444A patent/EP1890698B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| DE602006010542D1 (de) | 2009-12-31 |
| WO2006128468A1 (en) | 2006-12-07 |
| EP1890698A1 (en) | 2008-02-27 |
| US20090092573A1 (en) | 2009-04-09 |
| EP1890698B1 (en) | 2009-11-18 |
| ATE448786T1 (de) | 2009-12-15 |
| US8986668B2 (en) | 2015-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1890698T3 (da) | Fremgangsmåde til fremstilling af et nikotinafgivelses-produkt | |
| DE602007005024D1 (de) | Verfahren zur herstellung von konzentrierten tensidzusammensetzungen | |
| HK1258915A1 (zh) | 芳基-2-噁唑氰乙基氨基化合物、其製造方法及用法 | |
| CY1108411T1 (el) | Συνθεση περιεχουσα νικοτινη ελεγχομενης απελευθερωσης και μεθοδος | |
| NZ592152A (en) | Stable emulsions for producing polymer modified asphalt binders or cements | |
| DK1696923T3 (da) | Nikotinafgivelsesprodukt og fremgangsmåde til fremstilling deraf | |
| EP2327691A4 (en) | METHOD FOR PRODUCING A SULFURIC ACID GROUP-CONTAINING ETHER COMPOUND | |
| ZA201003221B (en) | Tea composition and process for the manufacture thereof | |
| EP1801145A4 (en) | METHOD FOR PRODUCING A HARDENED PRODUCT OF LIGHT SENSITIVE RESIN | |
| WO2009153285A3 (en) | 1,2-benzisothiazole compounds useful for combating animal pests | |
| FR2871804B1 (fr) | Procede de preparation d'un melange bitume-polymere | |
| ATE444950T1 (de) | Verfahren zur herstellung von 1-amino-3,5- dimethyladamantan-hydrochlorid | |
| DE60316573D1 (de) | Verfahren und vorrichtung für die herstellung einer ein bituminöses bindemittel enthaltenden baumischung | |
| ATE536864T1 (de) | Metoprololsuccinat tabletten mit verlängerter freisetzung und verfahren für deren herstellung | |
| MA32459B1 (fr) | Nouveaux derives tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| EP2163540A4 (en) | METHOD FOR THE PRODUCTION OF ETHYLENICALLY UNSATURATED ISOCYANATE WITH ETHER CONNECTION | |
| WO2008015133A3 (en) | Process for preparing amidrazones | |
| MA34089B1 (fr) | Composition herbicide et son procédé d'utilisation | |
| WO2008017020A3 (en) | Process for preparing proton pump inhibitors | |
| WO2009041475A1 (ja) | ピラゾール-3-イル-ベンズアミド誘導体の製造方法 | |
| WO2007116011A3 (de) | Substituierte triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel | |
| DE602006012622D1 (de) | Verfahren zur herstellung von 1,1,1-tris(4-hydroxyphenyl)alkanen | |
| WO2004105477A3 (fr) | Procede de clonage du rat par transfert nucleaire | |
| MX2009006449A (es) | Proceso para cosechar plantas de la familia apocynacea. | |
| DE502008002407D1 (de) | Verfahren zur herstellung carbonat-terminierter verbindungen |